All Articles

Amid crushing financial pressures on hospitals, one firm's staggering Q1 ROI suggests the future of revenue integrity isn't just AI, but AI guided by doctors.

New data shows Japanese finance chiefs are too slow to react to the BOJ's policy shifts, leading to real financial losses. The problem isn't awareness, but operational agility.

Neurizon Therapeutics completes enrollment for its NUZ-001 ALS trial at record speed, accelerating the timeline for potential new treatment data to 2027.

Digital evidence is burying police labs. A new on-premise AI promises to slash review times by up to 95%, but can it balance speed with legal scrutiny?

Amidst market headwinds, Westshore secures a landmark 10-year deal with Elk Valley Resources, boosting coal shipments and signaling long-term confidence.

With major design awards in Milan, PrimeBOT is pioneering a new 'Personal Robot' category that avoids human mimicry to create a true home companion.

As Nutrien prepares its Q2 2026 results, the ag giant's performance will offer a critical look into global food security and strategic innovation.

Targa Resources holds its dividend steady, signaling financial health. With massive growth projects underway, what should investors watch in its Q2 report?

Valero's steady $1.20 dividend isn't just good news for investors. It's a sign of robust health in both traditional refining and its growing low-carbon ventures.

The latest dividend from Carriage Services signals more than just shareholder returns; it reflects a disciplined strategy for growth in a rapidly evolving industry.

A record-breaking EOFY auction highlights a booming equipment market, fueled by a strategic acquisition, robust industrial activity, and global buyer demand.

As Essential Utilities preps its Q2 earnings, all eyes are on its grand strategy: a mega-merger, record infrastructure spending, and navigating costly new regulations.

A landmark $2B partnership with GDLS-Canada not only bolsters the CAF and aids Ukraine but signals a systemic shift in how Canada secures its sovereign capabilities.

Cellution Biologics' acquisition of SimpliDerm is more than a simple expansion. It's a tale of two diverging strategies in the high-stakes biologics market.

The real estate giant slashed its dividend by over 95%. It’s not a retreat, but a bold move to fund a war chest for AI and acquisitions in a consolidating market.

A hedge fund's demand for a sale puts a 94-year-old community bank at a crossroads, a case study in the fight for the soul of local American banking.

Beyond the pump, LV Petroleum's rapid expansion is a masterclass in strategic franchising and modernizing the American travel experience. What's driving it?

Ridgepost Capital's CEO Luke Sarsfield will keynote IPEM Global. This isn't just a speech; it's a calculated move to dominate the private markets stage.

With record $4B revenue, Alcoa makes its biggest move yet, acquiring South32 assets to become a bauxite titan while investing in future-proof tech.

ArcBest is simplifying its brand and cutting costs by $40M. We decode the signals behind this major move, from customer integration to workforce impact.